280 related articles for article (PubMed ID: 17224657)
1. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.
Ansari M; Krajinovic M
Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of childhood acute lymphoblastic leukemia.
Brenner TL; Pui CH; Evan WE
Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.
Davidsen ML; Dalhoff K; Schmiegelow K
J Pediatr Hematol Oncol; 2008 Nov; 30(11):831-49. PubMed ID: 18989161
[TBL] [Abstract][Full Text] [Related]
4. Genomic strategies to improve outcome and individualize therapy in cancer: the paradigm of childhood acute lymphoblastic leukemia.
Kager L
J BUON; 2009 Sep; 14 Suppl 1():S181-6. PubMed ID: 19785064
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenomics of acute lymphoblastic leukemia].
Ansari M; St-Onge G; Krajinovic M
Med Sci (Paris); 2007 Nov; 23(11):961-7. PubMed ID: 18021708
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of acute leukemia.
Ansari M; Krajinovic M
Pharmacogenomics; 2007 Jul; 8(7):817-34. PubMed ID: 18240908
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.
Aplenc R; Lange B
Br J Haematol; 2004 May; 125(4):421-34. PubMed ID: 15142113
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to cancer: why did this happen to my child?
Davies SM
Pediatr Blood Cancer; 2004 Oct; 43(5):536-8. PubMed ID: 15382268
[No Abstract] [Full Text] [Related]
10. Pharmacogenetics of childhood acute lymphoblastic leukemia.
Lopez-Lopez E; Gutierrez-Camino A; Bilbao-Aldaiturriaga N; Pombar-Gomez M; Martin-Guerrero I; Garcia-Orad A
Pharmacogenomics; 2014 Jul; 15(10):1383-98. PubMed ID: 25155938
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
Huang Y
Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of pediatric acute lymphoblastic leukemia.
Meeker ND; Yang JJ; Schiffman JD
Expert Opin Pharmacother; 2010 Jul; 11(10):1621-32. PubMed ID: 20429672
[TBL] [Abstract][Full Text] [Related]
13. Gene polymorphisms in childhood ALL.
Karathanasis NV; Choumerianou DM; Kalmanti M
Pediatr Blood Cancer; 2009 Mar; 52(3):318-23. PubMed ID: 18989891
[TBL] [Abstract][Full Text] [Related]
14. Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene.
Pietrzyk JJ; Bik-Multanowski M; Balwierz W; Skoczen S; Wojcik D; Chybicka A; Sikorska-Fic B; Matysiak M; Szczepanski T; Sonta-Jakimczyk D; Ploszynska A; Balcerska A; Mycko K; Bodalski J; Krawczuk-Rybak M; Kowalczyk J; Koltan A; Sobol G; Derwich K; Kwinta P
Pediatr Blood Cancer; 2009 Mar; 52(3):364-8. PubMed ID: 18989887
[TBL] [Abstract][Full Text] [Related]
15. Pathobiology and clinical significance of molecular genetic findings in childhood tumors.
Rubnitz JE; Downing JR; Crist WM
Adv Pediatr; 1998; 45():315-36. PubMed ID: 9742307
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
17. The genetic profile and monitoring of acute lymphoblastic leukemia in children and adolescents.
Mandrell BN
J Pediatr Nurs; 2009 Jun; 24(3):173-8. PubMed ID: 19467429
[TBL] [Abstract][Full Text] [Related]
18. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
Lehne G; Bjørheim J; Saeter G
Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
[TBL] [Abstract][Full Text] [Related]
19. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
20. Where can biology of childhood ALL be attacked by new compounds?
Bourquin JP; Izraeli S
Cancer Treat Rev; 2010 Jun; 36(4):298-306. PubMed ID: 20223597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
